| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023285 |
| Receipt No. | R000025650 |
| Official scientific title of the study | Usability of heart rate variability to evaluate the PECS block in post breast cancer operative pain |
| Date of disclosure of the study information | 2016/07/22 |
| Last modified on | 2016/07/22 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Usability of heart rate variability to evaluate the PECS block in post breast cancer operative pain | |
| Title of the study (Brief title) | Usability of heart rate variability to evaluate the PECS block in post breast cancer operative pain | |
| Region |
|
|
| Condition | ||
| Condition | breast cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | evaluation of PECS block |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of post breast cancer operative pain with HRV in post operative few hours |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | post breast cancer patients | |||
| Key exclusion criteria | diabetes mellitus
anxiety disoder operative massive hemorrhage arrhythmia |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Shinya Uchida |
| Organization | Gunma prefectural Cancer Center |
| Division name | anesthesiology |
| Address | 617-1 takabayasinisityou oota city gunma pref. |
| TEL | 0276-38-0771 |
| s_uchida@gunma-cc.jp | |
| Public contact | |
| Name of contact person | Shinya Uchida |
| Organization | Gunma prefectural Cancer Center |
| Division name | anesthesiology |
| Address | 617-1 takabayasinisityou oota city gunma pref. |
| TEL | 0276-38-0771 |
| Homepage URL | |
| s_uchida@gunma-cc.jp | |
| Sponsor | |
| Institute | Gunma prefectural Cancer Center
Department of anesthesiology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Gunma prefectural Cancer Center
Department of anesthesiology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | we finished this study without complications. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025650 |